Late pulmonary complications of treating Hodgkin lymphoma: bleomycin-induced toxicity

被引:12
|
作者
Jona, Adam [1 ,2 ]
Miltenyi, Zsofia [1 ,2 ]
Ujj, Zsofia [1 ,2 ]
Garai, Ildiko [3 ]
Szilasi, Maria [1 ,2 ]
Illes, Arpad [1 ,2 ]
机构
[1] Univ Debrecen, Ctr Clin, Inst Internal Med, Div Hematol, H-4032 Debrecen, Hungary
[2] Univ Debrecen, Dept Pulmonol, H-4032 Debrecen, Hungary
[3] Scanomed Ltd, Budapest, Hungary
关键词
bleomycin; Hodgkin lymphoma; pulmonary side effect; scintigraphy; CHEMOTHERAPY; DISEASE; LIFE;
D O I
10.1517/14740338.2014.946901
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: Survival of Hodgkin lymphoma (HL) patients has significantly improved in recent decades. The current first-line therapy is doxorubicin, bleomycin, vinblastine, dacarbazine (ABVD) +/- irradiation and may cause pulmonary toxicity. Strategies to reduce late toxicity as well as increase survival rate are of interest. Patients and methods: Pulmonary function of previously treated HL patients was collected over a 12-month period using St. George Respiratory Questionnaire (SGRQ), chest X-ray, dynamic inhalation lung scintigraphy and spirometry. Results: A total of 137 patients' data were reviewed. Median time elapsed since diagnosis was 11 years (range was 2 - 30 years). Chest irradiation did not significantly worsen pulmonary function. Number of ABVD cycles with consequential bleomycin dose showed significant correlation with SGRQ total score in patients receiving ABVD plus chest irradiation (p = 0.01). Scintigraphy results correlated with bleomycin dose in patients receiving ABVD without chest irradiation (right side: p = 0.099, left side: p = 0.051). Discussion: An additive negative effect of chest irradiation was not confirmed as reflected in the literature; however, increasing cumulative bleomycin dose worsened pulmonary function.
引用
收藏
页码:1291 / 1297
页数:7
相关论文
共 50 条
  • [21] Inhibitory effect of aminoguanidine on bleomycin-induced pulmonary toxicity in rat
    Chen, XL
    Huang, SS
    Li, WB
    Wang, DH
    Wang, XL
    ACTA PHARMACOLOGICA SINICA, 2001, 22 (08): : 711 - 715
  • [22] Bleomycin Pulmonary Toxicity in Adult Saudi Patients with Hodgkin's Lymphoma
    Al-Mansour, Mubarak M.
    Al-Jizani, Wafa A.
    Al-Fayea, Turki
    Ruaa, Shafi
    Kazkaz, Ghieth A.
    Bayer, Ali M.
    AL-Foheidi, Meteb
    Ibrahim, Ezzeldin M.
    BLOOD, 2014, 124 (21)
  • [23] Bleomycin pulmonary toxicity in adult Saudi patients with Hodgkin's lymphoma
    Al-Jizani, Wafa'a A.
    Al-Mansour, Mubarak M.
    Al-Fayea, Turki M.
    Shafi, Ruaa U.
    Kazkaz, Ghieth A.
    Bayer, Ali M.
    Al-Foheidi, Meteb E.
    Ibrahim, Ezzeldin M.
    FUTURE ONCOLOGY, 2015, 11 (15) : 2149 - 2157
  • [24] BLEOMYCIN-INDUCED PULMONARY FIBROSES
    LEREBOURSPIGEONNIERE, G
    MOORE, N
    GRES, JJ
    NOUVET, G
    BOISMARE, F
    MORERE, P
    THERAPIE, 1986, 41 (04): : 289 - 292
  • [25] Silymarin alleviates bleomycin-induced pulmonary toxicity and lipid peroxidation in mice
    Razavi-Azarkhiavi, Kamal
    Ali-Omrani, Mehdi
    Solgi, Reza
    Bagheri, Pezhman
    Haji-Noormohammadi, Mehdi
    Amani, Nahid
    Sepand, Mohammad-Reza
    PHARMACEUTICAL BIOLOGY, 2014, 52 (10) : 1267 - 1271
  • [26] The Integrin Inhibitor Cilengitide and Bleomycin-Induced Pulmonary Fibrosis Cilengitide and Bleomycin-Induced Pulmonary Fibrosis
    Ritzenthaler, Jeffrey D.
    Zhang, Michael
    Torres-Gonzalez, Edilson
    Roman, Jesse
    LUNG, 2020, 198 (06) : 947 - 955
  • [28] CIGARETTE-SMOKING IS A RISK FACTOR FOR BLEOMYCIN-INDUCED PULMONARY TOXICITY
    SENAN, S
    PAUL, J
    THOMSON, N
    KAYE, SB
    EUROPEAN JOURNAL OF CANCER, 1992, 28A (12) : 2084 - 2084
  • [29] Sesamol attenuates bleomycin-induced pulmonary toxicity and fibrosis in experimental animals
    Kaushik, Swati
    Bhargava, Poorva
    Sharma, Jatin
    Arava, Sudheer
    Nag, Tapas C.
    Arya, Dharamvir S.
    Bhatia, Jagriti
    JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 2023, 37 (11)
  • [30] Late pulmonary toxicity of bleomycin
    Willenbacher, W
    Mumm, A
    Bartsch, HH
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (09) : 3205 - 3205